MYLAN 233 (Efavirenz 600 mg)
This pill with imprint "MYLAN 233" is Yellow, Capsule-shape and has been identified as Efavirenz 600 mg. It is supplied by Mylan Pharmaceuticals Inc..
Efavirenz is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class NNRTIs. There is positive evidence of human fetal risk during pregnancy. Efavirenz 600 mg is not a controlled substance under the Controlled Substance Act (CSA).
Efavirenz
- Imprint:
- MYLAN 233
- Strength:
- 600 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- NNRTIs
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-2233
More about efavirenz
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 7 Reviews – Add your own review/rating
- Drug class: NNRTIs
Consumer resources
Other brands: Sustiva
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
